Artemis Investment Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Artemis Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-473,564	Closed	-$10.4M	–	233
2024 Q4	$10.4M	Sell	473,564 -69,340	-13%	-$1.26M	0.15%	137
2024 Q3	$9.78M	Buy	+542,904	New	+$9.5M	0.15%	137
2020 Q3	–	Sell	-50,000	Closed	-$618K	–	277
2020 Q2	$618K	Buy	+50,000	New	+$565K	0.01%	241
2015 Q2	–	Sell	-165,794	Closed	-$10.3M	–	282
2015 Q1	$10.3M	Buy	165,794 +104,394	+170%	+$6.07M	0.41%	56
2014 Q4	$3.53M	Buy	+61,400	New	+$3.42M	0.14%	144

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Artemis Investment Management's TEVA Position: Q1 2025 in Review

Artemis Investment Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2025, closing a stake of 473,564 shares — an estimated $10.4M sold.

Artemis Investment Management first reported a position in TEVA in Q4 2014 and held it in 5 quarters. The position peaked at $10.4M in Q4 2024. 562 funds tracked by Wall St. Rank hold TEVA as of Q1 2025.

Artemis Investment Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2025 after selling out during the quarter.
Artemis Investment Management sold 473,564 Teva Pharmaceutical Industries Limited shares in Q1 2025, an estimated $10.4M.
Artemis Investment Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2014 and held it in 5 quarters.
Artemis Investment Management's Teva Pharmaceutical Industries Limited position peaked at $10.4M in Q4 2024.
562 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2025.

Based on Artemis Investment Management's 13F filing for Q1 2025, filed 24 Apr 2025.